Xenova Group plc

Home
What is Brain Cancer?
About the Trial
Are You Eligible?
Participating Centre Locations
Useful Links
About Clinical Trials
FAQs
Glossary

Print Version

Q: HOW MANY PEOPLE HAVE USED TF-CRM107?
A: Approximately 70 patients to date, not including patients currently enrolled in the Phase III trial.




Back to FAQs

 
© 2006 Xenova Ltd